Stocks and Investing
Stocks and Investing
Mon, December 19, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Ed Arce Initiated (ACXP) at Strong Buy and Held Target at $14 on, Dec 19th, 2022
Ed Arce of HC Wainwright & Co., Initiated "Acurx Pharmaceuticals, Inc." (ACXP) at Strong Buy and Held Target at $14 on, Dec 19th, 2022.
Ed has made no other calls on ACXP in the last 4 months.
There is 1 other peer that has a rating on ACXP. Out of the 1 peers that are also analyzing ACXP, 0 agree with Ed's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ed
- James Molloy of "Alliance Global Partners" Initiated at Strong Buy and Held Target at $14 on, Thursday, October 20th, 2022
Contributing Sources